At the time of writing, Vaxart Inc [VXRT] stock is trading at $1.26, up 2.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VXRT shares have gain 16.67% over the last week, with a monthly amount drifted -10.00%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, March 2024, Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). In a post published today on Yahoo Finance, Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new President and Chief Executive Officer, Steven Lo, effective March 18, 2024. The awards were made pursuant to the Company’s previously disclosed offer letter with Mr. Lo, and as a material inducement to his joining the Company as President and Chief Executive Officer and a member of the Board of Directors.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on November 02, 2021, and set its price target to $15. On June 29, 2021, downgrade downgraded it’s rating to Neutral and revised its price target to $9 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $13 on June 24, 2021. Piper Sandler initiated its recommendation with a Overweight and recommended $18 as its price target on June 11, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 12, 2020, and upped its price target to $17. In a note dated July 13, 2020, B. Riley FBR initiated an Buy rating and provided a target price of $22 on this stock.
For the past year, the stock price of Vaxart Inc fluctuated between $0.53 and $1.59. Vaxart Inc [NASDAQ: VXRT] shares were valued at $1.26 at the most recent close of the market.
Analyzing the VXRT fundamentals
According to Vaxart Inc [NASDAQ:VXRT], the company’s sales were 7.38M for trailing twelve months, which represents an 14650.00% jump. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -39.02%, Pretax Profit Margin comes in at -35.55%, and Net Profit Margin reading is -35.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.84, Equity is -1.0 and Total Capital is -1.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2000 points at the first support level, and at 1.1400 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3000, and for the 2nd resistance point, it is at 1.3400.
Vaxart Inc [VXRT] reported earnings per share of -$0.12 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.14/share, meaning a difference of $0.02 and a surprise factor of 14.30%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.11 per share as compared to estimates of -$0.18 per share, a difference of $0.07 representing a surprise of 38.90%.
Ratios To Look Out For
It is important to note that Vaxart Inc [NASDAQ:VXRT] has a current ratio of 3.32. Also, the Quick Ratio is 3.32, while the Cash Ratio stands at 2.88. Considering the valuation of this stock, the price to sales ratio is 29.68, the price to book ratio is 3.34.
